US Phytoestrogen Supplements Market

ID: MRFR/Pharma/18465-HCR 100 Pages Nidhi Mandole Last Updated: September 10, 2026
US Phytoestrogen Supplements Market Research Report By Application (Food & Beverages, Nutraceutical, Cosmetics, Others), By Type (Flavonoids, Isoflavones, Daidzein, Genistein, Glycitein, Biochanin A, Others, Coumestans, Prenyl Flavonoids, Non-flavonoids, Lignans, Stilbenes), By Source (Nuts and oilseeds, Soy products, Cereals and breads, Legumes, Meat products, Others) and By End User (Hospitals & Clinics, Research Organizations, Others) - Growth & Industry Forecast 2025 To 2035
US Phytoestrogen Supplements Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.91%
2024 Market Size$ 313.95 Million
2025 Market Size$ 348.2 Million
2035 Market Size$ 980.7 Million
Key Players
Nature's Way
NOW Foods
Solgar
Garden of Life
Herbalife
GNC
Trends
  • Rising Demand for Natural Alternatives
  • Focus on Personalized Nutrition
  • Integration of Phytoestrogens in Functional Foods
Opportunities
  • Rising Interest in Plant-Based Diets
  • Increasing Awareness of Women's Health Issues
  • Growing Popularity of Holistic Health Approaches
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Million)
      1. 4.1.1 Flavonoids
      2. 4.1.2 Isoflavones
      3. 4.1.3 Daidzein
      4. 4.1.4 Genistein
      5. 4.1.5 Glycitein
      6. 4.1.6 Biochanin A
      7. 4.1.7 Others
      8. 4.1.8 Coumestans
      9. 4.1.9 Prenyl Flavonoids
      10. 4.1.10 Non-flavonoids
      11. 4.1.11 Lignans
      12. 4.1.12 Stilbenes
    2. 4.2 Medical Device, BY Source (USD Million)
      1. 4.2.1 Nuts and oilseeds
      2. 4.2.2 Soy products
      3. 4.2.3 Cereals and breads
      4. 4.2.4 Legumes
      5. 4.2.5 Meat products
      6. 4.2.6 Others
    3. 4.3 Medical Device, BY Application (USD Million)
      1. 4.3.1 Food & Beverages
      2. 4.3.2 Nutraceutical
      3. 4.3.3 Cosmetics
      4. 4.3.4 Others
    4. 4.4 Medical Device, BY End-User (USD Million)
      1. 4.4.1 Hospitals & Clinics
      2. 4.4.2 Research Organizations
      3. 4.4.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Nature's Way (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 NOW Foods (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Solgar (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Garden of Life (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Herbalife (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 GNC (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Swanson Health Products (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 NutraBlast (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY SOURCE
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 US MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY SOURCE, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY SOURCE, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY END-USER, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Phytoestrogen Supplements Market Segmentation

US Phytoestrogen Supplements Market By Type (USD Million, 2025-2035)

  • Flavonoids
  • Isoflavones
  • Daidzein
  • Genistein
  • Glycitein
  • Biochanin A
  • Others
  • Coumestans
  • Prenyl Flavonoids
  • Non-flavonoids
  • Lignans
  • Stilbenes

US Phytoestrogen Supplements Market By Source (USD Million, 2025-2035)

  • Nuts and oilseeds
  • Soy products
  • Cereals and breads
  • Legumes
  • Meat products
  • Others

US Phytoestrogen Supplements Market By Application (USD Million, 2025-2035)

  • Food & Beverages
  • Nutraceutical
  • Cosmetics
  • Others

US Phytoestrogen Supplements Market By End-User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Research Organizations
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.